OpenURL Connection Search

Select item for more details and to access through your institution.

Additional inspiratory resistance imposed by the laryngeal mask airway: in vitro versus in vivo comparison.
Published in:
Anaesthesia, 1997, v. 52, n. 9, p. 872, doi. 10.1111/j.1365-2044.1997.184-az0321.x
By:
- Righini, E. R.;
- Marangoni, E.;
- Volta, C. A.;
- Alvisi, R.;
- Bortolazzi, S.;
- Gritti, G.
Publication type:
Article
Breast cancer electron intraoperative radiotherapy: assessment of preoperative selection factors from a retrospective analysis of 758 patients and review of literature.
Published in:
Breast Cancer Research & Treatment, 2017, v. 165, n. 2, p. 261, doi. 10.1007/s10549-017-4321-6
By:
- Takanen, S.;
- Gambirasio, A.;
- Gritti, G.;
- Källi, M.;
- Andreoli, S.;
- Fortunato, M.;
- Feltre, L.;
- Filippone, F.;
- Iannacone, E.;
- Maffioletti, L.;
- Muni, R.;
- Piccoli, F.;
- Mauri, E.;
- Paludetti, A.;
- Giovanelli, M.;
- Burgoa, L.;
- Valerii, C.;
- Palamara, F.;
- Ferro, M.;
- Fenaroli, P.
Publication type:
Article
Validation of severity scoring systems SAPS II and APACHE II in a single-center population.
Published in:
2000
By:
- Capuzzo, M.;
- Valpondi, V.;
- Sgarbi, A.;
- Bortolazzi, S.;
- Pavoni, V.;
- Gilli, G.;
- Candini, G.;
- Gritti, G.;
- Alvisi, R.
Publication type:
journal article
Quality of life before intensive care admission: agreement between patient and relative assessment.
Published in:
2000
By:
- Capuzzo, M.;
- Grasselli, C.;
- Carrer, S.;
- Gritti, G.;
- Alvisi, R.
Publication type:
journal article
Validation of two quality of life questionnaires suitable for intensive care patients.
Published in:
2000
By:
- Capuzzo, Maurizia;
- Grasselli, Claudia;
- Carrer, Sara;
- Gritti, Gaetano;
- Alvisi, Raffaele;
- Capuzzo, M;
- Grasselli, C;
- Carrer, S;
- Gritti, G;
- Alvisi, R
Publication type:
journal article
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.
Published in:
Leukemia (08876924), 2014, v. 28, n. 3, p. 642, doi. 10.1038/leu.2013.334
By:
- Cortelezzi, A;
- Sciumè, M;
- Liberati, A M;
- Vincenti, D;
- Cuneo, A;
- Reda, G;
- Laurenti, L;
- Zaja, F;
- Marasca, R;
- Chiarenza, A;
- Gritti, G;
- Orsucci, L;
- Storti, S;
- Angelucci, E;
- Cascavilla, N;
- Gobbi, M;
- Mauro, F R;
- Morabito, F;
- Fabris, S;
- Piciocchi, A
Publication type:
Article
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status.
Published in:
2008
By:
- Cortelezzi, A.;
- Gritti, G.;
- Del Papa, N.;
- Pasquini, M. C.;
- Calori, R.;
- Gianelli, U.;
- Cortiana, M.;
- Parati, G.;
- Onida, F.;
- Sozzi, F.;
- Vener, C.;
- Bianchi, P.;
- Deliliers, G. L.
Publication type:
Letter
SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN PATIENTS WITH DLBCL. A MULTICENTER, OPEN‐LABEL, PHASE II TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 165, doi. 10.1002/hon.3163_T01
By:
- Stathis, A.;
- Hitz, F.;
- Schär, S.;
- Novak, U.;
- Fischer, N.;
- Mey, U.;
- Gritti, G.;
- Zander, T.;
- Lang, N.;
- Cairoli, A.;
- Zenz, T.;
- Rhyner, G.;
- Mingrone, W.;
- Schmidt, A.;
- Gaidano, G.;
- Hohaus, S.;
- Stern, A. O.;
- Mamot, C.;
- Bruscagin, A.;
- Musilova, J.
Publication type:
Article
COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE AND SHOWS EARLY EFFICACY IN PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 136, doi. 10.1002/hon.3163_91
By:
- Hutchings, M.;
- Dickinson, M.;
- Carlo‐Stella, C.;
- Morschhauser, F.;
- Bosch, F.;
- Gritti, G.;
- Townsend, W.;
- Bartlett, N. L.;
- Cartron, G.;
- Ghesquieres, H.;
- Houot, R.;
- Walter, H.;
- Offner, F.;
- Christiansen, A.;
- Dimier, N.;
- Jamois, C.;
- Harrop, E.;
- Herter, S.;
- Hölzlwimmer, G.;
- Keelara, A.
Publication type:
Article
Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: outcomes by baseline histology.
Published in:
Hematological Oncology, 2023, v. 41, p. 499, doi. 10.1002/hon.3164_367
By:
- Mehta‐Shah, N.;
- Jacobsen, E. D.;
- Zinzani, P. L.;
- Zain, J.;
- Mead, M.;
- Casulo, C.;
- Gritti, G.;
- Pinter‐Brown, L.;
- Izutsu, K.;
- Waters, S.;
- Brammer, J. E.;
- Pro, B.;
- Horwitz, S. M.
Publication type:
Article
NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.51_2879
By:
- Zinzani, P. L.;
- Santoro, A.;
- Gritti, G.;
- Brice, P.;
- Barr, P. M.;
- Kuruvilla, J.;
- Cunningham, D.;
- Kline, J.;
- Johnson, N. A.;
- Mehta‐Shah, N.;
- Fanale, M.;
- Francis, S.;
- Moskowitz, A. J.
Publication type:
Article
DEVELOPMENT AND VALIDATION OF A PET RADIOMICS PROGNOSTIC MODEL FOR DIFFUSE LARGE B CELL LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2879
By:
- Ceriani, L;
- Milan, L;
- Cascione, L;
- Gritti, G;
- Dalmasso, F;
- Esposito, F;
- Schär, Säm;
- Bruno, A;
- Dirnhofer, S;
- Giovanella, L;
- Hayoz, S;
- Mamot, C;
- Rambaldi, A;
- Chauvie, S;
- Zucca, E
Publication type:
Article
A NON‐INTERVENTIONAL STUDY OF OBINUTUZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (URBAN): IMPACT OF COVID‐19 PANDEMIC ON ENROLLMENT AND SAFETY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.25_2881
By:
- ., A;
- . Zinzani, P. L;
- . Arcaini, L;
- . Gritti, G;
- . Patti, C;
- . Pennese, E;
- . De Lorenzo, S;
- . Piparo, C;
- . Guardalben, E;
- . Ladetto, M
Publication type:
Article
POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.23_2880
By:
- Bannerji, R.;
- Yuen, S.;
- Phillips, T.;
- Arthur, C.;
- Isufi, I.;
- Marlton, P.;
- Seymour, J. F.;
- Corradini, P.;
- Molinari, A.;
- Gritti, G.;
- Emmons, R.;
- Hirata, J.;
- Musick, L.;
- Saha, S.;
- Croft, B.;
- Flowers, C.
Publication type:
Article
INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT.
Published in:
Hematological Oncology, 2019, v. 37, p. 77, doi. 10.1002/hon.47_2629
By:
- Ceriani, L.;
- Pirosa, M.;
- Stathis, A.;
- Gritti, G.;
- Ruberto, T.;
- Bruno, A.;
- Moccia, A.;
- Rambaldi, A.;
- Ferrari, S.;
- Giovannella, L.;
- Hayoz, S.;
- Mazzucchelli, L.;
- Dirnhofer, S.;
- Mamot, C.;
- Zucca, E.
Publication type:
Article
COPANLISIB SYNERGIES WITH CONVENTIONAL AND TARGETED AGENTS INCLUDING VENETOCLAX IN PRECLINICAL MODELS OF B‐ AND T‐CELL LYMPHOMAS.
Published in:
Hematological Oncology, 2019, v. 37, p. 318, doi. 10.1002/hon.127_2630
By:
- Tarantelli, C.;
- Lange, M.;
- Gaudio, E.;
- Cascione, L.;
- Spriano, F.;
- Kwee, I.;
- Arribas, A.;
- Rinaldi, A.;
- Jourdan, T.;
- Berthold, M.;
- Margheriti, F.;
- Gritti, G.;
- Rossi, D.;
- Stathis, A.;
- Liu, N.;
- Zucca, E.;
- Politz, O.;
- Bertoni, F.
Publication type:
Article
R‐CHOP PRECEDED BY ENGINEERED TUMOR NECROSIS FACTOR (TNF) IN RELAPSED OR REFRACTORY PRIMARY DIFFUSE LARGE B‐CELL LYMPHOMA OF THE CNS (rPCNSL): FINAL RESULTS OF THE INGRID TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 159, doi. 10.1002/hon.115_2629
By:
- Ferreri, A. J.;
- Calimeri, T.;
- Conte, G.;
- Ponzoni, M.;
- Fallanca, F.;
- Cattaneo, D.;
- Scarano, E.;
- Flavio, C.;
- Sassone, M.;
- Foppoli, M.;
- Perrone, S.;
- Cecchetti, C.;
- Lopedote, P.;
- Gritti, G.;
- Castellino, C.;
- Verga, L.;
- Olcese, F.;
- Mazza, R.;
- Ciceri, F.;
- Bordignon, C.
Publication type:
Article
NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE 2 CHECKMATE 436 STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 157, doi. 10.1002/hon.114_2629
By:
- Zinzani, P.L.;
- Santoro, A.;
- Gritti, G.;
- Brice, P.;
- Barr, P.M.;
- Kuruvilla, J.;
- Cunningham, D.;
- Kline, J.;
- Johnson, N.A.;
- Mehta‐Shah, N.A.;
- Manley, T.;
- Francis, S.;
- Sharma, M.;
- Moskowitz, A.J.
Publication type:
Article
DURABILITY OF COMPLETE RESPONSE AFTER BLINATUMOMAB THERAPY FOR REFRACTORY/RELAPSED AGGRESSIVE B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 429, doi. 10.1002/hon.102_2631
By:
- Viardot, A.;
- Hess, G.;
- Bargou, R.;
- Morley, N.J.;
- Gritti, G.;
- Iskander, K.;
- Cohan, D.;
- Zhang, A.;
- Franklin, J.;
- Coyle, L.
Publication type:
Article
INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT.
Published in:
Hematological Oncology, 2019, v. 37, p. 77, doi. 10.1002/hon.47_2629
By:
- Ceriani, L.;
- Pirosa, M.;
- Stathis, A.;
- Gritti, G.;
- Ruberto, T.;
- Bruno, A.;
- Moccia, A.;
- Rambaldi, A.;
- Ferrari, S.;
- Giovannella, L.;
- Hayoz, S.;
- Mazzucchelli, L.;
- Dirnhofer, S.;
- Mamot, C.;
- Zucca, E.
Publication type:
Article
COPANLISIB SYNERGIES WITH CONVENTIONAL AND TARGETED AGENTS INCLUDING VENETOCLAX IN PRECLINICAL MODELS OF B‐ AND T‐CELL LYMPHOMAS.
Published in:
Hematological Oncology, 2019, v. 37, p. 318, doi. 10.1002/hon.127_2630
By:
- Tarantelli, C.;
- Lange, M.;
- Gaudio, E.;
- Cascione, L.;
- Spriano, F.;
- Kwee, I.;
- Arribas, A.;
- Rinaldi, A.;
- Jourdan, T.;
- Berthold, M.;
- Margheriti, F.;
- Gritti, G.;
- Rossi, D.;
- Stathis, A.;
- Liu, N.;
- Zucca, E.;
- Politz, O.;
- Bertoni, F.
Publication type:
Article
R‐CHOP PRECEDED BY ENGINEERED TUMOR NECROSIS FACTOR (TNF) IN RELAPSED OR REFRACTORY PRIMARY DIFFUSE LARGE B‐CELL LYMPHOMA OF THE CNS (rPCNSL): FINAL RESULTS OF THE INGRID TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 159, doi. 10.1002/hon.115_2629
By:
- Ferreri, A. J.;
- Calimeri, T.;
- Conte, G.;
- Ponzoni, M.;
- Fallanca, F.;
- Cattaneo, D.;
- Scarano, E.;
- Flavio, C.;
- Sassone, M.;
- Foppoli, M.;
- Perrone, S.;
- Cecchetti, C.;
- Lopedote, P.;
- Gritti, G.;
- Castellino, C.;
- Verga, L.;
- Olcese, F.;
- Mazza, R.;
- Ciceri, F.;
- Bordignon, C.
Publication type:
Article
NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE 2 CHECKMATE 436 STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 157, doi. 10.1002/hon.114_2629
By:
- Zinzani, P.L.;
- Santoro, A.;
- Gritti, G.;
- Brice, P.;
- Barr, P.M.;
- Kuruvilla, J.;
- Cunningham, D.;
- Kline, J.;
- Johnson, N.A.;
- Mehta‐Shah, N.A.;
- Manley, T.;
- Francis, S.;
- Sharma, M.;
- Moskowitz, A.J.
Publication type:
Article
DURABILITY OF COMPLETE RESPONSE AFTER BLINATUMOMAB THERAPY FOR REFRACTORY/RELAPSED AGGRESSIVE B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 429, doi. 10.1002/hon.102_2631
By:
- Viardot, A.;
- Hess, G.;
- Bargou, R.;
- Morley, N.J.;
- Gritti, G.;
- Iskander, K.;
- Cohan, D.;
- Zhang, A.;
- Franklin, J.;
- Coyle, L.
Publication type:
Article
TAK-659, AN INVESTIGATIONAL REVERSIBLE DUAL SYK/FLT-3 INHIBITOR, IN PATIENTS WITH LYMPHOMA: UPDATED RESULTS FROM DOSE-ESCALATION AND EXPANSION COHORTS OF a PHASE 1 STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 72, doi. 10.1002/hon.2437_60
By:
- Kaplan, J.;
- Gordon, L.;
- Infante, J.;
- Popat, R.;
- Rambaldi, A.;
- Madan, S.;
- Patel, M.R.;
- Gritti, G.;
- El ‐ Sharkawi, D.;
- Chau, I.;
- Radford, J.;
- Perez De Oteyza, J.;
- Zinzani, P.;
- Iyer, S.;
- Faucette, S.;
- Sheldon ‐ Waniga, E.;
- Stumpo, K.;
- Shou, Y.;
- Carpio, C.;
- Bosch, F.
Publication type:
Article
Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer.
Published in:
British Journal of Cancer, 2000, v. 83, n. 5, p. 573, doi. 10.1054/bjoc.2000.1304
By:
- Beretta, G D;
- Michetti, G;
- Belometti, M O;
- Gritti, G;
- Quadri, A;
- Poletti, P;
- Labianca, R
Publication type:
Article

Found: 26